Asitri Dashboard Search Clinical Trials
The U.S. National Library of Medicine provides a database of clinical trials worldwide. Use the fields below to search the database. Expand your results and select terms or phrases and right-click to search using Google, MalaCards, MedlinePlus, PubMed, or Wikipedia.
Saved Searches
Choose Search
Basic Search
Clinical Trials Search Results
Search History:
Count: 408
Selected: 0
| NCT ID | Title | ||
|---|---|---|---|
| NCT01329952 | Reinfection and Long Term Outcomes in Intravenous Drug Users (IVDUs) After Hepatitis C Treatment | ||
| NCT02822547 | Study on Treatment of Pegylated Interferon Alfa 2a(Pegasys®) in the Korean Chronic Hepatitis B(CHB) Adults | ||
| NCT05387616 | A Prospective Multicenter Phase 2 Study of the Chemotherapy-Free Combination of the Intravenous Phosphatidylinositol-3-Kinase (PI3K) Inhibitor Copanlisib in Combination With Obinutuzumab in Patients With Previously Untreated Follicular Lymphoma (FL) and a High Tumor Burden | ||
| NCT01249638 | Cap+Bev vs Cap+Iri+Bev 1st-line Therapy in mCRC | ||
| NCT01028092 | mTor-inhibitor (EVERolimus) Based Immunosuppressive Strategies for CNI Minimisation in OLD for Old Renal Transplantation | ||
| NCT00352092 | Pilot Study for HLA Identical Living Donor Renal Transplant Recipients | ||
| NCT03590535 | 5th Generation cTnT in ED ACS | ||
| NCT00201825 | A Phase II Study of Capecitabine and Docetaxel in Previously Untreated Advanced Non-Small Cell Lung Cancer Patients | ||
| NCT06068985 | Classifying for HER2 Dependence to De-Escalate Neoadjuvant Chemotherapy in Patients With HER2+ Early Breast Cancer Undergoing HER2 Double-Blockade | ||
| NCT06191068 | Canadian CHO-KLAT/H-FIT Study - Quality of Life of, and Burden of Caring for, Persons With Hemophilia | ||
| NCT07387848 | Glofitamab as a Bridge to and/or Consolidation Post Autologous Stem Cell Transplant in Patients With Relapsed B Cell Lymphomas | ||
| NCT00177255 | A Study of Docetaxel in Combination With Capecitabine in Stomach and Esophagus Cancers | ||
| NCT01167049 | Xeloda Plus Paclitaxel in Gastric Cancer With Liver Metastasis | ||
| NCT02323555 | Optimize the Requirements and Preparations in Outpatient Chemotherapy | ||
| NCT00275535 | The Comparison of Tacrolimus and Sirolimus Immunosuppression Based Drug Regimens in Kidney Transplant Recipients | ||
| NCT00910676 | Study About Preventive Treatment of Folliculitis Induced by Epidermal Growth Factor Receptor Inhibitors | ||
| NCT03301493 | Genomic Testing and Resulting Medical Decisions | ||
| NCT02626845 | Rituximab for the Otolaryngologic Manifestations of Granulomatosis With Polyangiitis | ||
| NCT00189683 | Xeloda Vs Monitoring in Advanced Colorectal Cancer Responsive to Chemotherapy | ||
| NCT00384566 | A Comparison of the Effect of Carvedilol and Metoprolol on Airways Tone in Patients With Heart Failure | ||
| NCT00205556 | Effect of Increased Convective Clearance by On-Line Hemodiafiltration on All Cause Mortality in Chronic Hemodialysis Patients | ||
| NCT00957866 | Prospective Anti-Hepatitis C Virus (Anti-HCV) Trial of Peg-Interferon and Ribavirin in Subjects of First Nations, Metis and Caucasian Ethnicity | ||
| NCT00219739 | STI571 ProspectIve RandomIzed Trial: SPIRIT | ||
| NCT01674738 | TS Stratified Chemotherapy and VEGF Inhibition in Non-Squamous Non-Small Cell Lung Cancer - Stage IV | ||
| NCT03911219 | Impact of eHealth Monitoring on Overall Survival in Patients With Metastatic NSCLC / Extensive-stage SCLC / Advanced TNBC Under First-line Treatment With Atezolizumab Plus Chemotherapy | ||
| NCT04490044 | Under and Over Rehabilitation Study | ||
| NCT00476164 | Study of Rituximab to Treat Chronic Renal Transplant Rejection | ||
| NCT01118234 | Rituximab Versus Observation as Maintenance Therapy in Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia) | ||
| NCT02120911 | Feasibility Study of Chemoradiation, TRAstuzumab and Pertuzumab in Resectable HER2+ Esophageal Carcinoma | ||
| NCT00938444 | Evaluation of the BRADA and ABILHAND Questionnaires | ||
| NCT00539838 | A Study to Evaluate Two Doses of Ocrelizumab in Patients With Active Systemic Lupus Erythematosus (BEGIN) | ||
| NCT05293015 | NP-Supported Multidisciplinary Diabetes Management During Perioperative Period | ||
| NCT01709097 | Compliance/Adherence After Kidney Transplant, With or With Out Med-O-Wheel™. | ||
| NCT05911178 | Impact of Microglial Activation on Synaptic Density in Alzheimer's Disease | ||
| NCT02562378 | T-DM1 and Non-pegylated Liposomal Doxorubicin in Human Epidermal Growth Factor Receptor 2 (HER2)-Positive Metastatic Breast Cancer | ||
| NCT01593332 | Low Dose Rituximab as a First Line Biologic Therapy for the Treatment of DMARD Resistant Patients With Rheumatoid Arthritis | ||
| NCT02776566 | Patient-Centered Anticoagulation Self-Monitoring in Minority Patients | ||
| NCT00193609 | Oxaliplatin and Capecitabine in the Treatment of Relapsed/Refractory Carcinoma of Unknown Primary Site | ||
| NCT01188707 | A Trial of Belinostat in Combination With Erlotinib in Patients With Non-small Cell Lung Cancer | ||
| NCT04059887 | Evaluation of Blood TMB for the Efficacy of Atezolizumab [BUDDY] | ||
| NCT02436707 | Novel Combination Therapy in the Treatment of Relapsed and Refractory Aggressive B-Cell Lymphoma | ||
| NCT00562770 | Oral Valganciclovir Versus Valacyclovir | ||
| NCT03721653 | FOLFOXIRI + Bev + Atezo vs FOLFOXIRI + Bev as First-line Treatment of Unresectable Metastatic Colorectal Cancer Patients | ||
| NCT01472029 | Explorative Phase II Study of Perioperative Treatment in Patients With Adenocarcinoma of the Gastroesophageal Junction or Stomach | ||
| NCT07365930 | NIS on the Benefits of TIPS in Patients With HCC Receiving Atezo+Bev in 1st-Line Therapy | ||
| NCT05038657 | Atezolizumab Immunotherapy, in Immunotherapy Naive Patients With Urinary Tract Squamous Cell Carcinoma (UTSCC). | ||
| NCT04484636 | PLATON - Platform for Analyzing Targetable Tumor Mutations (Pilot-study) | ||
| NCT04462276 | Thoracic RadiothErapy With Atezolizumab in Small Cell lUng canceR Extensive Disease | ||
| NCT00784446 | First-line Therapy of Stage IV Colorectal Cancer | ||
| NCT01022541 | Capecitabine and Oxaliplatin Plus Bevacizumab as Neoadjuvant Treatment for Untreated Unresectable Liver-only Metastases From Colorectal Cancer |
